Ha! No challenge whatsover. Remember, SPA was reneged by FDA because they did not think that reducing triglycerides reduces heart disease. Plus, there are so many other benefits to Vascepa that are hardly being acknowledged at the moment such as reduced inflammation. As the other benefits of Vascepa become more widely known, this Matinas study will be more meaningless than it already is.
Haha! Great analogy! Listening to JT is like watching paint dry but, if it gets the job done...then, it is just a matter of patience.
That's true, the person may not have had the chance to post them here. Nobody is obligated to post the script numbers here. It is nice that Keystone is willing to do so when able to. That they aren't posted, my imagination runs away with me and I think Keystone saw them and they were so bad, decided against it.
I agree with you! If the scripts were good, at least we would know that there is continuous growth - even if not reflected in the PPS. But, without the scripts and the falling pps, makes me think someone knows and it isn't good news. I hope I am wrong but that is exactly what it seems like.
We shouldn't be writing to the FDA and politicians, we should be writing to GSK, AZN and PFE...they seem to be missing some vital information! LOL!
Sentiment: Strong Buy
Who is providing script numbers now? I cannot remember who provided them last week. Was it here or on a different forum? ST/iHub?
Sentiment: Strong Buy
"BP will not touch until our challenges have been resolved. " ... BP has the $$$ and influence to help resolve these problems. In the meantime, GSK is losing revenues due to generic Lovaza. It seems that BP is purposely or stupidly missing the EPA story and dismissing the value that Vascepa has to offer to the both the company who ultimately owns it and the patients who will benefit from it.
that Amarin and Vascepa are going to ride off and disappear quietly into the sunset? It is all good and well to think that management #$%$ up royally or that FDA has it in for Amarin or that BP is paying off someone to ensure the obstacles we are seeing but at the end of the day, Vascepa is a safe and effective drug that fulfills a need in the market. That is the reality. That is what matters!
Wow, wow, wow! Oh my God, you're brilliant insights are just overwhelming! You must be a multi-billionaire with these amazing insights! Do you know anything about Amarin apart from PPS and revenues? Have you ever heard of the concept of new product launch? Your approach is about as sound as using a crystal ball made of plastic. Actually, I think the crystal ball made of plastic would be more accurate. Yeah, Chapter 11 is inevitable. Now go away.